2. Definition
It is a clinical syndrome characterized by decreased
myocardial performance leading to over activation
of neuro-endocrine system, hypo perfusion of
peripheral system, systemic and pulmonary
congestion.
9. Management
Symptomatic relief
1. Diurestics
2. Nebulization
3. Propup position
Beta blockers if CI then Ivabredine if CI then Digoxin
ARNIs/ACEi/ARBs if CI then Hydralazine/ Nitrates
MRAs (spiromide)
SGLT2 inhibitors (Empagloflozin)
10. Cntd.
Patient education
HTN, DM management
Lifestyle modification
Salt and water restriction
Encourage exercise if tolerable